Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis

被引:0
|
作者
Weibo Zhong
Kaihui Wu
Zining Long
Xumin Zhou
Chuanfan Zhong
Shuo Wang
Houhua Lai
Yufei Guo
Daojun Lv
Jianming Lu
Xiangming Mao
机构
[1] Southern Medical University,Department of Urology, Zhujiang Hospital
[2] The Third Affiliated Hospital of Guangzhou Medical University,Department of Urology
[3] Guangzhou Medical University,Department of Andrology, Guangzhou First People’s Hospital, School of Medicine
来源
Microbiome | / 10卷
关键词
Gut dysbiosis; Prostate cancer; Lipopolysaccharide; NF-κB-IL6-STAT3 axis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
    Zhong, Weibo
    Wu, Kaihui
    Long, Zining
    Zhou, Xumin
    Zhong, Chuanfan
    Wang, Shuo
    Lai, Houhua
    Guo, Yufei
    Lv, Daojun
    Lu, Jianming
    Mao, Xiangming
    MICROBIOME, 2022, 10 (01)
  • [2] Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis
    Zhang, Hualin
    Song, Yang
    Yang, Huimin
    Liu, Zhiyan
    Gao, Lifen
    Liang, Xiaohong
    Ma, Chunhong
    ONCOGENE, 2018, 37 (18) : 2456 - 2468
  • [3] Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis
    Hualin Zhang
    Yang Song
    Huimin Yang
    Zhiyan Liu
    Lifen Gao
    Xiaohong Liang
    Chunhong Ma
    Oncogene, 2018, 37 : 2456 - 2468
  • [4] IL-8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF-κB pathway in prostate cancer
    Guo, Yidi
    Zang, Ying
    Lv, Lianzheng
    Cai, Feng
    Qian, Tingting
    Zhang, Guoying
    Feng, Quancheng
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 9035 - 9042
  • [5] Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling
    Liu, Shasha
    Zhang, Chaoqi
    Wang, Boqiao
    Zhang, Huanyu
    Qin, Guohui
    Li, Congcong
    Cao, Ling
    Gao, Qun
    Ping, Yu
    Zhang, Kai
    Lian, Jingyao
    Zhao, Qitai
    Wang, Dan
    Zhang, Zhen
    Zhao, Xuan
    Yang, Li
    Huang, Lan
    Yang, Bo
    Zhang, Yi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2601 - 2616
  • [6] Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
    Chen, Xiao-Wu
    Zhou, Shu-Feng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2941 - 2946
  • [7] Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer
    Huang, Shuai
    Wa, Qingde
    Pan, Jincheng
    Peng, Xinsheng
    Ren, Dong
    Huang, Yan
    Chen, Xiao
    Tang, Yubo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [8] Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer
    Shuai Huang
    Qingde Wa
    Jincheng Pan
    Xinsheng Peng
    Dong Ren
    Yan Huang
    Xiao Chen
    Yubo Tang
    Journal of Experimental & Clinical Cancer Research, 36
  • [9] MiR-449a promotes breast cancer progression by activating the NF-κB pathway
    Shi, Wei
    Lee, Matthew
    Kogo, Ryunosuke
    Bruce, Jeff
    How, Christine
    Yip, Kenneth W.
    Liu, Fei-Fei
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction
    Liu, Bin
    Xu, Tonghong
    Xu, Xinning
    Cui, Yuzhu
    Xing, Xiaojing
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 449 (1-2) : 285 - 294